LUND, SE / ACCESS Newswire / January 22, 2025 / Alligator Bioscience (STO:ATORX)Sharpened focus on mitazalimab and cost-reduction program to maximize long-term value creationAnnouncement of rights iss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback